Acromegaly
Acromegaly is a rare hormonal disorder characterized by excessive growth hormone (GH) production, typically due to a benign pituitary adenoma. It occurs in adults after epiphyseal closure, leading to progressive somatic disfigurement, including enlarged hands and feet, altered facial features, thickened skin, and organomegaly. Common symptoms involve joint pain, carpal tunnel syndrome, sleep apnea, hypertension, and increased risk of type 2 diabetes. If untreated, acromegaly results in significant morbidity and premature mortality. Diagnosis relies on elevated GH and insulin-like growth factor-1 (IGF-1) levels, along with imaging to identify pituitary tumors. Treatment primarily involves surgical removal of the tumor, supplemented by medications or radiation therapy when needed. The condition most commonly affects individuals aged 30–50, though it can occur at any age; when it develops before growth plate fusion, it causes gigantism. Acromegaly may also be associated with certain genetic syndromes, including MEN1, MEN4, McCune-Albright syndrome, and Carney complex.
References:
-
Acromegaly (1)
By Targets:
Loading...
Show More (1)
By Categories:
Loading...
Show More (1)
By Clinical Status:
Loading...
Show More (1)
Acromegaly
Clear Filters
Tezusomant
Cat. No.: HY-P10964
CAS No.: 2802416-72-2
- Formula: C120H171N23O32S
- Molecular Weight: 2479.84
Tezusomant is a growth hormone receptor antagonist. Tezusomant is promising for research on diseases caused by excessive growth hormone secretion, such as acromegaly.
loading...
Please select quantity
Get Quote
August 31
-
Please select quantity
August 31
Get Quote
loading...
Related Small Molecules
Related Proteins